Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Initiation

Initiation

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Guggenheim Initiates Coverage On Confluent with Buy Rating, Announces Price Target of $29

By Benzinga Newsdesk
January 27, 5:58 AM
Guggenheim analyst Howard Ma initiates coverage on Confluent (NASDAQ:CFLT) with a Buy rating and announces Price Target of $29.

CFLT

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Guggenheim Initiates Coverage On Couchbase with Buy Rating, Announces Price Target of $20

By Benzinga Newsdesk
January 27, 5:54 AM
Guggenheim analyst Howard Ma initiates coverage on Couchbase (NASDAQ:BASE) with a Buy rating and announces Price Target of $20.

BASE

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Stifel Initiates Coverage On Compass Therapeutics with Buy Rating, Announces Price Target of $9

By Benzinga Newsdesk
January 27, 5:50 AM
Stifel analyst Stephen Willey initiates coverage on Compass Therapeutics (NASDAQ:CMPX) with a Buy rating and announces Price Target of $9.

CMPX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Gaming
  • General
  • Initiation

Why This Roblox Analyst Prefers To Be On The Sidelines

By Priya Nigam
January 26, 1:19 PM
Shares of Roblox Corp (NYSE: RBLX) started Thursday with a steep decline, giving up gains recorded in the previous trading session.

RBLX

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Concerns Over Tinder’s Prospects Despite Match’s Multiple Catalysts Keeps Analyst At Sidelines

By Anusuya Lahiri
January 26, 1:15 PM
Citigroup analyst Ygal Arounian initiated coverage on Match Group Inc (NASDAQ:MTCH) with a Neutral rating and a price target of $55. Match…

MTCH

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Initiation
  • News
  • Tech
  • Top Stories

Could Datadog’s TAM Reach $62B — Maybe $70B? Yes, But It Depends On This: Analyst

By Priya Nigam
January 26, 1:07 PM
Shares of Datadog Inc (NASDAQ: DDOG) spiked during Thursday’s early trading session.

DDOG

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Chardan Capital Initiates Coverage On Coya Therapeutics with Buy Rating, Announces Price Target of $9

By Benzinga Newsdesk
January 26, 7:25 AM
Chardan Capital analyst Keay Nakae initiates coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and announces Price Target of $9.

COYA

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Wolfe Research Initiates Coverage On DexCom with Outperform Rating, Announces Price Target of $121

By Benzinga Newsdesk
January 26, 6:49 AM
Wolfe Research analyst Mike Polark initiates coverage on DexCom (NASDAQ:DXCM) with a Outperform rating and announces Price Target of $121.

DXCM

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News

Wolfe Research Initiates Coverage On Insulet with Peer Perform Rating

By Benzinga Newsdesk
January 26, 6:48 AM
Wolfe Research analyst Mike Polark initiates coverage on Insulet (NASDAQ:PODD) with a Peer Perform rating.

PODD

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Cantor Fitzgerald Initiates Coverage On Datadog with Overweight Rating, Announces Price Target of $95

By Benzinga Newsdesk
January 26, 5:42 AM
Cantor Fitzgerald analyst Jonathan Ruykhaver initiates coverage on Datadog (NASDAQ:DDOG) with a Overweight rating and announces Price Target of $95.

DDOG

Posts pagination

Previous 1 … 84 85 86 … 272 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service